Skip to main content
. 2012 Nov 1;75(6):1478–1487. doi: 10.1111/bcp.12019

Figure 2.

Figure 2

Single and repeat dose median plasma semi-log concentration–time profiles for fluticasone furoate (FF; 0–48 h) and vilanterol trifenatate (VI; 0–12 h) after co-administration of ketoconazole or placebo and FF/VI (study 2). Inline graphic, single dose FF/VI + placebo; Inline graphic, single dose FF/VI + ketoconazole; Inline graphic, repeat dose FF/VI + placebo; Inline graphic, repeat dose FF/VI + ketoconazole; and Inline graphic, lower limit of quantification (LLQ) 10 pg ml–1